Skip to main content

Table 2 League table of the results of network meta-analysis

From: Network meta-analysis of invasive treatment for early-stage osteonecrosis of the femoral head

  

CD

6.27 (− 5.21, 17.98)

11.61 (− 3.36, 26.80)

3.83 (− 6.02, 13.67)

8.74 (2.36, 15.25)

7.07 (− 7.76, 21.56)

HHS Score

 

CD

 

BG

5.38 (− 13.63, 24.29)

 − 2.44 (− 14.05, 9.03)

2.48 (− 10.07, 15.05)

0.77 (− 17.97, 19.23)

 
 

2.16 (0.39, 13.13)

BG

 

CD + PRP

 − 7.83 (− 25.87, 10.18)

 − 2.88 (− 19.16, 13.41)

 − 4.57 (− 25.77, 16.39)

 
 

3.59 (0.69, 29.66)

1.69 (0.14, 24.83)

CD + PRP

 

CD + BG

4.91 (− 5.27, 15.21)

3.27 (− 14.57, 20.83)

 
 

3.3 (1.08, 10.65)

1.51 (0.29, 8.07)

0.91 (0.09, 7.05)

CD + BG

 

CD + BMMSC

 − 1.66 (− 17.90, 14.14)

 
 

10.13 (1.14, 116.98)

4.68 (0.38, 71.25)

2.77 (0.14, 54.07)

3 (0.48, 26.84)

CD + BG + BMMSC

 

CD + SAI

 

Clinical Failure Rate

2.92 (1.58, 5.61)

1.36 (0.21, 8.14)

0.81 (0.09, 4.84)

0.88 (0.26, 2.92)

0.29 (0.02, 2.68)

CD + BMMSC

  
  1. The left lower part is the league table of clinical failure rate, risk ratio and 95% credit interval are presented in it; and the right upper part is the league table of the HHS score, mean difference and 95%CrI are presented in it
  2. CD Core decompression, BG Bone grafting, PRP Platelet-rich plasma, BMMSC Bone marrow mesenchymal stem cells, SAI Superselective arterial infusion
  3. In comparison to CD alone, CD+BG, CD+BG+BMMSC, and CD+BMMSC all exhibit significant statistical significance and demonstrate superior efficacy compared to CD alone